MDLN · Medline Inc
Price
Snapshot
50 fields · last close| Market Cap | $48.11B |
| P/E | 67.50 |
| Float | 541.3M |
| Beta | 0.78 |
| Volatility | 19.5% |
| Exchange | NASDAQ |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 68 |
| Price | 36.60 |
| Change | +0.03% |
| Prev Close | 36.59 |
| Open | 36.52 |
| Day Low | 35.55 |
| Day High | 36.93 |
| Avg Vol | 7 |
| Avg $ Vol | $267.3M |
| 52W High | 50.88 |
| 52W Low | 32.48 |
| 52W Pos | 22.4% |
| From High | −28.06% |
| From Low | +12.67% |
| Max DD 1Y | −34.83% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +4.79% |
| SMA 50 | −3.20% |
| SMA 200 | — |
| RSI (14) | 53.0 |
| Vol 30D | 58.6% |
| Vol 90D | 52.8% |
| 1Y Range | 32–51 |
| Daily bars | 179 |
| Perf Week | +5.60% |
| Perf Month | −0.20% |
| Perf Quarter | +6.21% |
| Perf Half Y | −16.94% |
| Perf Year | — |
| Perf YTD | −9.90% |
| Prev Day | +0.03% |
| Clavix | B |
| Debt / Eq | 1.17 |
| Curr Ratio | 4.29 |
| Int Cover | 2.7× |
| FCF Margin | 3.4% |
| Rev Growth | +11.6% |
| Profit | Profitable |
| Leverage | Moderate |
| Sector rank | 38 / 47 |
Clavix risk grade
regraded every trading dayMDLN grades B, 68 of 100. Steadiest on Macro Resilience (68), most exposed on Price Stability (48, fragile). 1 of the 4 weighted dimensions sit above the Health Care median. Ranks 38 of 47 in Health Care by Clavix score.
How rough the ride is
| MDLN | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.78 | 0.81 |
| Volatilityannualized | 19.5% | 20.4% |
| Max drawdown, past yearworst peak-to-trough fall | −34.8% | — |
| Typical daily movemedian absolute daily change | 1.88% | — |
| Days beyond ±3%of the last 178 sessions | 5229% | — |
How its days are spread
Daily returns over the last 178 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| MDLN | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.78 | 0.81 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate55% of 47 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| MDLN | |
|---|---|
| 1 week | +5.6% |
| 1 month | −0.2% |
| Year to date | −9.9% |
| 1 year | — |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| MDLN | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 20 Jul |
| Average score0 most bearish, 100 most bullish | 35 |
| Bullish · bearisharticles above 60 · below 40 | 6 · 21 |
| Directionarticles whose tone is improving vs worsening | 6 ↑ 21 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 47 Health Care names Clavix covers; the tick is the sector median.
Growth
| MDLN | |
|---|---|
| Revenue growthyear over year | +11.6% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Against Health Care
47 companies| Metric | MDLN | Sector spread | Median |
|---|---|---|---|
| Beta | 0.78 | 0.81 | |
| Volatility | 19.5% | 20.4% | |
| P/E | 67.50 | 26.14 | |
| Debt / equity | 1.17 | 0.71 | |
| Current ratio | 4.29 | 1.58 | |
| FCF margin | 3.4% | 8.6% | |
| Interest coverage | 2.7× | 6.3× |
Recent news
most recent scored articles · the chip is the article’s score · click to openLaw firm Kaplan Fox & Kilsheimer announced on September 4, 2026 that it is investigating Medline Inc. for potential violations of securities laws. The firm is asking investors who lost money on Medline, or anyone with relevant information, to contact them.
Law firm Kaplan Fox & Kilsheimer LLP announced it is investigating Medline Inc. for potential securities violations and is soliciting investors who suffered losses to come forward.
Law firm Kaplan Fox & Kilsheimer LLP announced on August 31, 2026 that it is investigating Medline Inc. for possible securities law violations, and is asking affected investors to contact them.
AVID Medical is recalling convenience kits that contain Medline Namic Angiographic Star Off Handle Manifolds, which were already subject to a separate Medline recall. The article provides no details on the number of kits affected, the reason for the recall, or the financial impact.
The law firm Kaplan Fox & Kilsheimer LLP announced it is investigating Medline Inc. for potential securities law violations and is asking investors who suffered losses to contact the firm.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| HUM | Humana Inc | B | $48.82B | 37.87 | 0.68 | Compare |
| BDX | Becton Dickinson and Co | A- | $51.11B | 54.01 | 0.24 | Compare |
| EW | Edwards Lifesciences Corp | A- | $51.75B | 51.53 | 0.84 | Compare |
| IDXX | IDEXX Laboratories Inc | B+ | $41.70B | 36.69 | 1.57 | Compare |
| CAH | Cardinal Health Inc | A- | $57.82B | 33.59 | 0.54 | Compare |
| COR | Cencora Inc | B+ | $64.35B | 24.52 | 0.59 | Compare |
| VEEV | Veeva Systems Inc | B- | $34.18B | 45.52 | 0.91 | Compare |
| BSX | Boston Scientific Corp | B | $68.04B | 18.98 | 0.59 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.